nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—CHRM5—Tiotropium—chronic obstructive pulmonary disease	0.186	0.242	CbGbCtD
Fesoterodine—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.119	0.155	CbGbCtD
Fesoterodine—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.103	0.135	CbGbCtD
Fesoterodine—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.0954	0.124	CbGbCtD
Fesoterodine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.039	0.0508	CbGbCtD
Fesoterodine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.039	0.0508	CbGbCtD
Fesoterodine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0348	0.0452	CbGbCtD
Fesoterodine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0327	0.0426	CbGbCtD
Fesoterodine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0221	0.0288	CbGbCtD
Fesoterodine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0211	0.0274	CbGbCtD
Fesoterodine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0188	0.0245	CbGbCtD
Fesoterodine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0184	0.024	CbGbCtD
Fesoterodine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0174	0.0226	CbGbCtD
Fesoterodine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.011	0.0144	CbGbCtD
Fesoterodine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0104	0.0136	CbGbCtD
Fesoterodine—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.000755	0.00385	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000752	0.00384	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.000747	0.00381	CcSEcCtD
Fesoterodine—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000734	0.00374	CcSEcCtD
Fesoterodine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000731	0.00373	CcSEcCtD
Fesoterodine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000727	0.00371	CcSEcCtD
Fesoterodine—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.000725	0.0037	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00072	0.00368	CcSEcCtD
Fesoterodine—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.000717	0.00366	CcSEcCtD
Fesoterodine—Infestation—Montelukast—chronic obstructive pulmonary disease	0.000717	0.00366	CcSEcCtD
Fesoterodine—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000713	0.00364	CcSEcCtD
Fesoterodine—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000711	0.00363	CcSEcCtD
Fesoterodine—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.000711	0.00363	CcSEcCtD
Fesoterodine—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000686	0.0035	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000678	0.00346	CcSEcCtD
Fesoterodine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000678	0.00346	CcSEcCtD
Fesoterodine—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000672	0.00343	CcSEcCtD
Fesoterodine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000668	0.00341	CcSEcCtD
Fesoterodine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000664	0.00339	CcSEcCtD
Fesoterodine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00066	0.00337	CcSEcCtD
Fesoterodine—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000649	0.00331	CcSEcCtD
Fesoterodine—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000649	0.00331	CcSEcCtD
Fesoterodine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000648	0.0033	CcSEcCtD
Fesoterodine—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.000647	0.0033	CcSEcCtD
Fesoterodine—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.000647	0.0033	CcSEcCtD
Fesoterodine—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000644	0.00329	CcSEcCtD
Fesoterodine—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000644	0.00329	CcSEcCtD
Fesoterodine—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000636	0.00324	CcSEcCtD
Fesoterodine—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000631	0.00322	CcSEcCtD
Fesoterodine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000629	0.00321	CcSEcCtD
Fesoterodine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000626	0.0032	CcSEcCtD
Fesoterodine—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000618	0.00316	CcSEcCtD
Fesoterodine—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000613	0.00313	CcSEcCtD
Fesoterodine—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00061	0.00311	CcSEcCtD
Fesoterodine—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00061	0.00311	CcSEcCtD
Fesoterodine—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000609	0.00311	CcSEcCtD
Fesoterodine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000608	0.0031	CcSEcCtD
Fesoterodine—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000608	0.0031	CcSEcCtD
Fesoterodine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000603	0.00308	CcSEcCtD
Fesoterodine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000602	0.00307	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000599	0.00306	CcSEcCtD
Fesoterodine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000599	0.00305	CcSEcCtD
Fesoterodine—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000597	0.00305	CcSEcCtD
Fesoterodine—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000592	0.00302	CcSEcCtD
Fesoterodine—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000592	0.00302	CcSEcCtD
Fesoterodine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00059	0.00301	CcSEcCtD
Fesoterodine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00058	0.00296	CcSEcCtD
Fesoterodine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00058	0.00296	CcSEcCtD
Fesoterodine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000579	0.00296	CcSEcCtD
Fesoterodine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000576	0.00294	CcSEcCtD
Fesoterodine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000576	0.00294	CcSEcCtD
Fesoterodine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000576	0.00294	CcSEcCtD
Fesoterodine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000576	0.00294	CcSEcCtD
Fesoterodine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000575	0.00293	CcSEcCtD
Fesoterodine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000567	0.00289	CcSEcCtD
Fesoterodine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000565	0.00288	CcSEcCtD
Fesoterodine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000564	0.00288	CcSEcCtD
Fesoterodine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000562	0.00287	CcSEcCtD
Fesoterodine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00056	0.00286	CcSEcCtD
Fesoterodine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00056	0.00286	CcSEcCtD
Fesoterodine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000559	0.00285	CcSEcCtD
Fesoterodine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000555	0.00283	CcSEcCtD
Fesoterodine—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000553	0.00282	CcSEcCtD
Fesoterodine—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000553	0.00282	CcSEcCtD
Fesoterodine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000546	0.00279	CcSEcCtD
Fesoterodine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000544	0.00277	CcSEcCtD
Fesoterodine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00054	0.00276	CcSEcCtD
Fesoterodine—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000532	0.00272	CcSEcCtD
Fesoterodine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000529	0.0027	CcSEcCtD
Fesoterodine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000523	0.00267	CcSEcCtD
Fesoterodine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000523	0.00267	CcSEcCtD
Fesoterodine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000523	0.00267	CcSEcCtD
Fesoterodine—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000522	0.00267	CcSEcCtD
Fesoterodine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000512	0.00261	CcSEcCtD
Fesoterodine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000509	0.0026	CcSEcCtD
Fesoterodine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000505	0.00258	CcSEcCtD
Fesoterodine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000505	0.00258	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000502	0.00256	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000499	0.00255	CcSEcCtD
Fesoterodine—Cough—Formoterol—chronic obstructive pulmonary disease	0.000499	0.00255	CcSEcCtD
Fesoterodine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000499	0.00255	CcSEcCtD
Fesoterodine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000495	0.00253	CcSEcCtD
Fesoterodine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000495	0.00252	CcSEcCtD
Fesoterodine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000493	0.00252	CcSEcCtD
Fesoterodine—Cough—Montelukast—chronic obstructive pulmonary disease	0.000489	0.00249	CcSEcCtD
Fesoterodine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000487	0.00249	CcSEcCtD
Fesoterodine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000487	0.00248	CcSEcCtD
Fesoterodine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000487	0.00248	CcSEcCtD
Fesoterodine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000485	0.00248	CcSEcCtD
Fesoterodine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000485	0.00247	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000484	0.00247	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000484	0.00247	CcSEcCtD
Fesoterodine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000477	0.00244	CcSEcCtD
Fesoterodine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000476	0.00243	CcSEcCtD
Fesoterodine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000476	0.00243	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000474	0.00242	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000473	0.00241	CcSEcCtD
Fesoterodine—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000471	0.00241	CcSEcCtD
Fesoterodine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000471	0.0024	CcSEcCtD
Fesoterodine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000464	0.00237	CcSEcCtD
Fesoterodine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000464	0.00237	CcSEcCtD
Fesoterodine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00046	0.00235	CcSEcCtD
Fesoterodine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00046	0.00234	CcSEcCtD
Fesoterodine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000458	0.00234	CcSEcCtD
Fesoterodine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000458	0.00234	CcSEcCtD
Fesoterodine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000457	0.00233	CcSEcCtD
Fesoterodine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000456	0.00232	CcSEcCtD
Fesoterodine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000456	0.00232	CcSEcCtD
Fesoterodine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000454	0.00232	CcSEcCtD
Fesoterodine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000453	0.00231	CcSEcCtD
Fesoterodine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000453	0.00231	CcSEcCtD
Fesoterodine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000452	0.00231	CcSEcCtD
Fesoterodine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.00229	CcSEcCtD
Fesoterodine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000448	0.00229	CcSEcCtD
Fesoterodine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000444	0.00227	CcSEcCtD
Fesoterodine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.00223	CcSEcCtD
Fesoterodine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000434	0.00221	CcSEcCtD
Fesoterodine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000432	0.00221	CcSEcCtD
Fesoterodine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00043	0.0022	CcSEcCtD
Fesoterodine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000428	0.00218	CcSEcCtD
Fesoterodine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000426	0.00217	CcSEcCtD
Fesoterodine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000422	0.00215	CcSEcCtD
Fesoterodine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000422	0.00215	CcSEcCtD
Fesoterodine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00042	0.00214	CcSEcCtD
Fesoterodine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000415	0.00212	CcSEcCtD
Fesoterodine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000415	0.00212	CcSEcCtD
Fesoterodine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000414	0.00211	CcSEcCtD
Fesoterodine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000411	0.0021	CcSEcCtD
Fesoterodine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000411	0.0021	CcSEcCtD
Fesoterodine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000409	0.00209	CcSEcCtD
Fesoterodine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000406	0.00207	CcSEcCtD
Fesoterodine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000406	0.00207	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000403	0.00206	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000403	0.00206	CcSEcCtD
Fesoterodine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000402	0.00205	CcSEcCtD
Fesoterodine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000402	0.00205	CcSEcCtD
Fesoterodine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.00205	CcSEcCtD
Fesoterodine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000399	0.00204	CcSEcCtD
Fesoterodine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000399	0.00204	CcSEcCtD
Fesoterodine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00203	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000395	0.00201	CcSEcCtD
Fesoterodine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000394	0.00201	CcSEcCtD
Fesoterodine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.002	CcSEcCtD
Fesoterodine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.00198	CcSEcCtD
Fesoterodine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000387	0.00197	CcSEcCtD
Fesoterodine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000386	0.00197	CcSEcCtD
Fesoterodine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00196	CcSEcCtD
Fesoterodine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00196	CcSEcCtD
Fesoterodine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000384	0.00196	CcSEcCtD
Fesoterodine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000383	0.00195	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000382	0.00195	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000382	0.00195	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000381	0.00194	CcSEcCtD
Fesoterodine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.00194	CcSEcCtD
Fesoterodine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000377	0.00192	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000374	0.00191	CcSEcCtD
Fesoterodine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000371	0.00189	CcSEcCtD
Fesoterodine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000371	0.00189	CcSEcCtD
Fesoterodine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000369	0.00188	CcSEcCtD
Fesoterodine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000369	0.00188	CcSEcCtD
Fesoterodine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000365	0.00186	CcSEcCtD
Fesoterodine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000364	0.00186	CcSEcCtD
Fesoterodine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000364	0.00186	CcSEcCtD
Fesoterodine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000363	0.00185	CcSEcCtD
Fesoterodine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00185	CcSEcCtD
Fesoterodine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000362	0.00185	CcSEcCtD
Fesoterodine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000361	0.00184	CcSEcCtD
Fesoterodine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000361	0.00184	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.00184	CcSEcCtD
Fesoterodine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.00179	CcSEcCtD
Fesoterodine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.00178	CcSEcCtD
Fesoterodine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00175	CcSEcCtD
Fesoterodine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00175	CcSEcCtD
Fesoterodine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000344	0.00175	CcSEcCtD
Fesoterodine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000343	0.00175	CcSEcCtD
Fesoterodine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00172	CcSEcCtD
Fesoterodine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000335	0.00171	CcSEcCtD
Fesoterodine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.00171	CcSEcCtD
Fesoterodine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00169	CcSEcCtD
Fesoterodine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00169	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00033	0.00168	CcSEcCtD
Fesoterodine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000328	0.00167	CcSEcCtD
Fesoterodine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00166	CcSEcCtD
Fesoterodine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000323	0.00165	CcSEcCtD
Fesoterodine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000319	0.00163	CcSEcCtD
Fesoterodine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000319	0.00163	CcSEcCtD
Fesoterodine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.00161	CcSEcCtD
Fesoterodine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000313	0.0016	CcSEcCtD
Fesoterodine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.00159	CcSEcCtD
Fesoterodine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000309	0.00158	CcSEcCtD
Fesoterodine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.00158	CcSEcCtD
Fesoterodine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000302	0.00154	CcSEcCtD
Fesoterodine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.00154	CcSEcCtD
Fesoterodine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000294	0.0015	CcSEcCtD
Fesoterodine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.0015	CcSEcCtD
Fesoterodine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.0015	CcSEcCtD
Fesoterodine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000294	0.0015	CcSEcCtD
Fesoterodine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000292	0.00149	CcSEcCtD
Fesoterodine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000292	0.00149	CcSEcCtD
Fesoterodine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000292	0.00149	CcSEcCtD
Fesoterodine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.00149	CcSEcCtD
Fesoterodine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000288	0.00147	CcSEcCtD
Fesoterodine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000288	0.00147	CcSEcCtD
Fesoterodine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000286	0.00146	CcSEcCtD
Fesoterodine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000283	0.00144	CcSEcCtD
Fesoterodine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000278	0.00142	CcSEcCtD
Fesoterodine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00142	CcSEcCtD
Fesoterodine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00142	CcSEcCtD
Fesoterodine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000277	0.00141	CcSEcCtD
Fesoterodine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.00141	CcSEcCtD
Fesoterodine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.00141	CcSEcCtD
Fesoterodine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000272	0.00139	CcSEcCtD
Fesoterodine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00134	CcSEcCtD
Fesoterodine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000247	0.00126	CcSEcCtD
Fesoterodine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000242	0.00123	CcSEcCtD
Fesoterodine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.00117	CcSEcCtD
Fesoterodine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000227	0.00116	CcSEcCtD
Fesoterodine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000212	0.00108	CcSEcCtD
Fesoterodine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.00106	CcSEcCtD
Fesoterodine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00105	CcSEcCtD
Fesoterodine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000202	0.00103	CcSEcCtD
Fesoterodine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.00102	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000971	CcSEcCtD
Fesoterodine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00095	CcSEcCtD
Fesoterodine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000931	CcSEcCtD
Fesoterodine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00018	0.000919	CcSEcCtD
Fesoterodine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000915	CcSEcCtD
Fesoterodine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000911	CcSEcCtD
Fesoterodine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.000853	CcSEcCtD
Fesoterodine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000848	CcSEcCtD
Fesoterodine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000825	CcSEcCtD
Fesoterodine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.000813	CcSEcCtD
Fesoterodine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.000813	CcSEcCtD
Fesoterodine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000808	CcSEcCtD
Fesoterodine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.000808	CcSEcCtD
Fesoterodine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000802	CcSEcCtD
Fesoterodine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000772	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000767	CcSEcCtD
Fesoterodine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.000766	CcSEcCtD
Fesoterodine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000745	CcSEcCtD
Fesoterodine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000741	CcSEcCtD
Fesoterodine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000691	CcSEcCtD
Fesoterodine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000673	CcSEcCtD
Fesoterodine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000663	CcSEcCtD
Fesoterodine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000641	CcSEcCtD
Fesoterodine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00062	CcSEcCtD
Fesoterodine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000591	CcSEcCtD
Fesoterodine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000591	CcSEcCtD
Fesoterodine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000587	CcSEcCtD
Fesoterodine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000557	CcSEcCtD
Fesoterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.16e-05	0.00117	CbGpPWpGaD
Fesoterodine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.16e-05	0.00117	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GC—chronic obstructive pulmonary disease	4.06e-05	0.00114	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	4e-05	0.00113	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.99e-05	0.00112	CbGpPWpGaD
Fesoterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.99e-05	0.00112	CbGpPWpGaD
Fesoterodine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.98e-05	0.00112	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.98e-05	0.00112	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.96e-05	0.00112	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.94e-05	0.00111	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.94e-05	0.00111	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.94e-05	0.00111	CbGpPWpGaD
Fesoterodine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	3.94e-05	0.00111	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.93e-05	0.00111	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.91e-05	0.0011	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.78e-05	0.00106	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.77e-05	0.00106	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.77e-05	0.00106	CbGpPWpGaD
Fesoterodine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.72e-05	0.00105	CbGpPWpGaD
Fesoterodine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	3.72e-05	0.00105	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.71e-05	0.00105	CbGpPWpGaD
Fesoterodine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	3.7e-05	0.00104	CbGpPWpGaD
Fesoterodine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	3.67e-05	0.00103	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.62e-05	0.00102	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.61e-05	0.00102	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.58e-05	0.00101	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.55e-05	0.001	CbGpPWpGaD
Fesoterodine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.52e-05	0.000991	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.5e-05	0.000987	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.49e-05	0.000984	CbGpPWpGaD
Fesoterodine—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	3.49e-05	0.000983	CbGpPWpGaD
Fesoterodine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.47e-05	0.000977	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.46e-05	0.000976	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.46e-05	0.000975	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.45e-05	0.000973	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.42e-05	0.000963	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.37e-05	0.00095	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.37e-05	0.000949	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.32e-05	0.000935	CbGpPWpGaD
Fesoterodine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.23e-05	0.000911	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.23e-05	0.00091	CbGpPWpGaD
Fesoterodine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.19e-05	0.000898	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.18e-05	0.000895	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.17e-05	0.000894	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.17e-05	0.000894	CbGpPWpGaD
Fesoterodine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.06e-05	0.000863	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.04e-05	0.000857	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.04e-05	0.000856	CbGpPWpGaD
Fesoterodine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.03e-05	0.000853	CbGpPWpGaD
Fesoterodine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.02e-05	0.000851	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.01e-05	0.000849	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.9e-05	0.000818	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.88e-05	0.000813	CbGpPWpGaD
Fesoterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.81e-05	0.000792	CbGpPWpGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.8e-05	0.000789	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.78e-05	0.000783	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.77e-05	0.000781	CbGpPWpGaD
Fesoterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.77e-05	0.000781	CbGpPWpGaD
Fesoterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.76e-05	0.000779	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.72e-05	0.000766	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.65e-05	0.000748	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.65e-05	0.000747	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.65e-05	0.000746	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.63e-05	0.000743	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.62e-05	0.000739	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.58e-05	0.000726	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.52e-05	0.000711	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.5e-05	0.000705	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.5e-05	0.000704	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.49e-05	0.000703	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.47e-05	0.000696	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.46e-05	0.000695	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.46e-05	0.000692	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.43e-05	0.000685	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.4e-05	0.000675	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.32e-05	0.000654	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.27e-05	0.00064	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.26e-05	0.000638	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.26e-05	0.000636	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.25e-05	0.000634	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.24e-05	0.000632	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.24e-05	0.00063	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.23e-05	0.000628	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.22e-05	0.000626	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.22e-05	0.000625	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.21e-05	0.000622	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GCLC—chronic obstructive pulmonary disease	2.19e-05	0.000618	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.16e-05	0.000608	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.14e-05	0.000604	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.14e-05	0.000603	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.14e-05	0.000603	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.13e-05	0.000601	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.13e-05	0.000601	CbGpPWpGaD
Fesoterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.13e-05	0.0006	CbGpPWpGaD
Fesoterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.12e-05	0.000599	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.11e-05	0.000595	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.11e-05	0.000595	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.07e-05	0.000582	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.05e-05	0.000579	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.03e-05	0.000572	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.02e-05	0.000571	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2e-05	0.000565	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CTGF—chronic obstructive pulmonary disease	2e-05	0.000564	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.99e-05	0.000561	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.97e-05	0.000554	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.96e-05	0.000551	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.95e-05	0.00055	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.93e-05	0.000544	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.93e-05	0.000543	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.91e-05	0.000537	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.84e-05	0.00052	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.84e-05	0.000517	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.79e-05	0.000505	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.78e-05	0.000501	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.78e-05	0.000501	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.77e-05	0.000499	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.75e-05	0.000494	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.72e-05	0.000484	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.7e-05	0.00048	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.63e-05	0.00046	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.63e-05	0.000459	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.62e-05	0.000456	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.62e-05	0.000456	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.59e-05	0.000448	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.56e-05	0.000441	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.56e-05	0.00044	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.56e-05	0.000439	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.56e-05	0.000439	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.55e-05	0.000436	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.54e-05	0.000435	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.54e-05	0.000434	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.52e-05	0.000428	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.49e-05	0.00042	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.48e-05	0.000416	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.45e-05	0.00041	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.45e-05	0.000409	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.45e-05	0.000408	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.44e-05	0.000405	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.41e-05	0.000398	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.41e-05	0.000397	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.39e-05	0.000392	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.39e-05	0.000391	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.34e-05	0.000378	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.34e-05	0.000378	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.34e-05	0.000377	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.33e-05	0.000374	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.32e-05	0.000373	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.31e-05	0.00037	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.27e-05	0.000358	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.23e-05	0.000348	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.21e-05	0.000341	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.2e-05	0.00034	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.2e-05	0.000338	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.2e-05	0.000337	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.2e-05	0.000337	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.19e-05	0.000336	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.19e-05	0.000335	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.18e-05	0.000334	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.17e-05	0.00033	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.14e-05	0.000321	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.14e-05	0.00032	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.1e-05	0.000311	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.1e-05	0.000309	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.09e-05	0.000308	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.09e-05	0.000307	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.09e-05	0.000306	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.09e-05	0.000306	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.08e-05	0.000306	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.08e-05	0.000305	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.08e-05	0.000303	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.05e-05	0.000296	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.05e-05	0.000295	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.04e-05	0.000293	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.04e-05	0.000292	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.76e-06	0.000275	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.76e-06	0.000275	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.72e-06	0.000274	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.63e-06	0.000271	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.62e-06	0.000271	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.61e-06	0.000271	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.21e-06	0.00026	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.2e-06	0.000259	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.14e-06	0.000258	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	9.11e-06	0.000257	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.07e-06	0.000256	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.97e-06	0.000253	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.75e-06	0.000247	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	8.71e-06	0.000246	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.7e-06	0.000245	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.67e-06	0.000245	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.57e-06	0.000242	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.5e-06	0.00024	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.45e-06	0.000238	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.33e-06	0.000235	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.02e-06	0.000226	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.01e-06	0.000226	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8e-06	0.000225	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.92e-06	0.000223	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.82e-06	0.000221	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.81e-06	0.00022	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.65e-06	0.000216	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.63e-06	0.000215	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.56e-06	0.000213	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.48e-06	0.000211	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.31e-06	0.000206	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.29e-06	0.000205	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.21e-06	0.000203	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.21e-06	0.000203	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.17e-06	0.000202	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.03e-06	0.000198	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.86e-06	0.000193	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.73e-06	0.00019	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.48e-06	0.000183	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.46e-06	0.000182	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.4e-06	0.00018	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.16e-06	0.000174	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.14e-06	0.000173	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.09e-06	0.000172	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.01e-06	0.000169	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.93e-06	0.000167	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.9e-06	0.000166	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.86e-06	0.000165	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.84e-06	0.000165	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.79e-06	0.000163	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	5.78e-06	0.000163	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.65e-06	0.000159	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.53e-06	0.000156	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.53e-06	0.000156	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	5.45e-06	0.000154	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.4e-06	0.000152	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.27e-06	0.000148	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.25e-06	0.000148	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.24e-06	0.000148	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.21e-06	0.000147	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.2e-06	0.000147	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.17e-06	0.000146	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.83e-06	0.000136	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.82e-06	0.000136	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.77e-06	0.000134	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.74e-06	0.000134	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.72e-06	0.000133	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.68e-06	0.000132	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.98e-06	0.000112	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.97e-06	0.000112	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.93e-06	0.000111	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.64e-06	0.000103	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.63e-06	0.000102	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.59e-06	0.000101	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.56e-06	0.0001	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.41e-06	9.6e-05	CbGpPWpGaD
